Heparanase in primary human osteoblasts

Journal of Orthopaedic Research

Volumn 28, Issue 10, 2010, Pages 1315-1322

  Smith, Paul N ^a,b   Freeman, Craig ^c   Yu, Di ^a   Chen, Mingming ^a   Gatenby, Paul A ^a   Parish, Christopher R ^c   Li, Rachel W ^a,b  

^a The Australian National University   (Australia)

^b CANBERRA HOSPITAL   (Australia)

^c Biology and Environment   (Australia)

Author keywords

Extracellular matrix; Gene expression; Heparanase; Osteoblasts; Osteogenesis

Indexed keywords

ALKALINE PHOSPHATASE; HEPARANASE; HISTONE H3; BETA GLUCURONIDASE; BIOLOGICAL MARKER; HISTONE;

ADULT; AGED; ARTICLE; BONE DEVELOPMENT; BONE TURNOVER; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRABECULAR BONE; CASE CONTROL STUDY; CELL CULTURE; ENZYMOLOGY; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

AGED; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; GLUCURONIDASE; HISTONES; HUMANS; MALE; MIDDLE AGED; OSTEOBLASTS; OSTEOGENESIS; OSTEOPOROSIS;

EID: 77957194384     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21138     Document Type: Article

References (32)

1. Brown AJ, Alicknavitch M, D'Souza SS, et al. 2008. Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation. Bone 43:689-699.
2. Moretti M, Sinnappah-Kang ND, Toller M, et al. 2006. HPSE-1 expression and functionality in differentiating neural cells. J Neurosci Res 83:694-701.
3. Kjellen L, Lindahl U. 1991. Proteoglycans: structures and interactions. Annu Rev Biochem 60:443-475.
4. Kolset SO, Ehlorsson J, Kjellen L, et al. 1986. Effect of benzyl beta-D-xyloside on the biosynthesis of chondroitin sulphate proteoglycan in cultured human monocytes. Biochem J 238:209-216. (Pubitemid 16024997)
5. Lidholt K, Kjellen L, Lindahl U. 1989. Biosynthesis of heparin. Relationship between the polymerization and sulphation processes. Biochem J 261:999-1007.
6. Bishop JR, Schuksz M, Esko JD. 2007. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446:1030-1037.
7. Davidson B, Vintman L, Zcharia E, et al. 2004. Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma. Clin Exp Metastasis 21:469-476.
8. Rops AL, van der Vlag J, Lensen JF, et al. 2004. Heparan sulfate proteoglycans in glomerular inflammation. Kidney Int 65:768-785.
9. Vlodavsky I, Korner G, Ishai-Michaeli R, et al. 1990. Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev 9:203-226.
10. Teplyuk NM, Haupt LM, Ling L, et al. 2009. The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signalling axis in osteoblasts. J Cell Biochem 107:144-154.
11. Parish CR, Freeman C, Brown KJ, et al. 1999. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res 59:3433-3441. (Pubitemid 29334505)
12. Vlodavsky I, Friedmann Y, Elkin M, et al. 1999. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5:793-802.
13. Ilan N, Elkin M, Vlodavsky I. 2006. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 38:2018-2039. (Pubitemid 44397619)
14. Parish CR. 2006. The role of heparan sulphate in inflammation. Nat Rev Immunol 6:633-643.
15. Fitzgerald M, Hayward IP, Thomas AC, et al. 1999. Matrix metalloproteinase can facilitate the heparanase-induced promotion of phenotype change in vascular smooth muscle cells. Atherosclerosis 145:97-106.
16. Vlodavsky I, Elkin M, Pappo O, et al. 2000. Mammalian heparanase as mediator of tumor metastasis and angiogenesis. Isr Med Assoc J 2:37-45.
17. Saijo M, Kitazawa R, Nakajima M, et al. 2003. Heparanase mRNA expression during fracture repair in mice. Histochem Cell Biol 120:493-503. (Pubitemid 38058204)
18. Kram V, Zcharia E, Yacoby-Zeevi O, et al. 2006. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass. J Cell Physiol 207:784-792.
19. Kelly T, Suva LJ, Huan Y, et al. 2005. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases. Cancer Res 65:5778-5784.
20. Altundag K, Altundag O, Baptista MZ, et al. 2005. Heparanase activity and bone loss in postmenopausal breast cancer patients. J Clin Oncol 23:8916-8917. (Pubitemid 46211541)
21. Altundag K, Altundag O, Baptista MZ, et al. 2005. Is there an association between high heparanase level and osteoporosis risk in breast cancer patients without clinical evidence of bone metastases? Osteoporos Int 16:2195-2196.
22. Stanford CM, Jacobson PA, Eanes ED, et al. 1995. Rapidly forming apartitic mineral in osteoblast cell line (UMR106-01 BMP). J Biol Chem 270:9420-9428.
23. Freeman C, Parish CR. 1997. A rapid quantitative assay for the detection of mammalian heparanase activity. Biochem J 325:229-237.
24. Li RW, Freeman C, Yu D, et al. 2008. Dramatic regulation of heparanase activity and angiogenesis gene expression in synovium from patients with rheumatoid arthritis. Arthritis Rheum 58:1590-1600.
25. Levy-Adam F, Abboud-Jarrous G, Guerrini M, et al. 2005. Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase. J Biol Chem 280:20457-20466.
26. Zetser A, Bashenko Y, Miao HQ, et al. 2003. Heparanase affects adhesive and tumorigenic potential of human glioma cells. Cancer Res 63:7733-7741. (Pubitemid 37466704)
27. Vlodavsky I, Ilan N, Naggi A, et al. 2007. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des 13:2057-2073.
28. Bandyopadhyay A, Tsuji K, Cox K, et al. 2006. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet 2:e216.
29. Naomoto Y, Gunduz M, Takaoka M, et al. 2007. Heparanase promotes angiogenesis through Cox-2 and HIF1alpha. Med Hypotheses 68:162-165.
30. Nobuhisa T, Naomoto Y, Okawa T, et al. 2007. Translocation of heparanase into nucleus results in cell differentiation. Cancer Sci 98:535-540.
31. Hendzel MJ, Wei Y, Mancini MA, et al. 1997. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106:348-360.
32. Datta HK, Ng WF, Walker JA, et al. 2008. The cell biology of bone metabolism. J Clin Pathol 61:577-587.